Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome. Journal of Clinical Investigation , 2024; 134 (15) DOI: 10.1172/JCI169893 Cite This Page : ...

Antiphospholipid syndrome is usually treated with blood thinners that patients take for the rest of their lives. Unfortunately, blood thinning medicines don't prevent future blood clots in all ...

Bikdeli estimates that antiphospholipid syndrome is the cause of 50,000-100,000 strokes, 100,000 cases of myocardial infarction (MI), and 30,000 cases of deep vein thrombosis every year. "It is a ...

Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series. Pediatric Rheumatology , 2022; 20 (1) DOI: 10.1186/s12969-022-00677-8 ...

SAN DIEGO — Primary prevention remains the biggest treatment challenge in antiphospholipid syndrome, according to a speaker at the Congress of Clinical Rheumatology West.

SAN DIEGO — Preventing the first thrombosis, and better circumvention of the second, are currently the biggest obstacles in managing antiphospholipid syndrome, according to a speaker at the 2024 ...

Hughes syndrome, also known as “sticky blood syndrome” or antiphospholipid syndrome (APS), affects the way that your blood clots. Learn more.

Antiphospholipid syndrome (APS) is an autoimmune disorder characterised by the persistent presence of antiphospholipid antibodies (aPL), which significantly increase the risk of thrombosis and ...

That’s what happens in Antiphospholipid Antibody Syndrome (APS). It’s a health issue most people haven’t heard of, but it can lead to serious problems like blood clots, strokes, and ...

Antiphospholipid syndrome (APS) ... This PrimeView focuses on the pathophysiology of APS, which is mainly characterized by thrombosis and obstetrical complications. PrimeView 11 Jan 2018.

In the antiphospholipid syndrome, the major target of antiphospholipid antibodies is β 2-glycoprotein I (β 2 GPI), a plasma protein that binds avidly to phospholipid surfaces, even more so when ...